William Blair analyst Matt Phipps reiterated an Outperform rating on Autolus Therapeutics plc (NASDAQ: AUTL)The analyst commented, "Autolus shares are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE